Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT04113226 ·Status: UNKNOWN ·Phase: PHASE2

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199 ·Status: COMPLETED ·Phase: PHASE3

Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

NCT03602131 ·Status: UNKNOWN ·Phase: PHASE2

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667 ·Status: COMPLETED ·Phase: PHASE2

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

NCT00140569 ·Status: COMPLETED ·Phase: PHASE3

IMPACT Non Hodgkins Lymphoma (NHL) Study

NCT00903812 ·Status: COMPLETED

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936 ·Status: COMPLETED ·Phase: PHASE3

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

NCT01553786 ·Status: COMPLETED ·Phase: PHASE2

Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs

NCT05284396 ·Status: UNKNOWN

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

NCT00001301 ·Status: COMPLETED

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

NCT05524298 ·Status: RECRUITING

Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

NCT03552003 ·Status: RECRUITING

Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma

NCT02313389 ·Status: UNKNOWN ·Phase: PHASE3

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00204659 ·Status: COMPLETED ·Phase: PHASE2

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NCT00561379 ·Status: COMPLETED ·Phase: NA

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00003150 ·Status: COMPLETED ·Phase: PHASE3

Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation

NCT01820117 ·Status: COMPLETED

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

NCT03513601 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.

NCT01848132 ·Status: COMPLETED ·Phase: PHASE2

Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9

NCT00400907 ·Status: UNKNOWN

Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma

NCT04183569 ·Status: UNKNOWN

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

NCT00553943 ·Status: COMPLETED ·Phase: PHASE2

Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

NCT00902434 ·Status: COMPLETED

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

NCT06813573 ·Status: RECRUITING ·Phase: NA